Can methyldopa influence the outcomes of cardiac rehabilitation programs in hypertensive patients and what role does it play in improving exercise tolerance?
Lakshya KumarExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Methyldopa can reduce blood pressure in hypertensive patients, potentially enhancing their ability to participate in and benefit from cardiac rehabilitation by improving exercise tolerance and overall cardiovascular health.
Methyldopa, by managing hypertension effectively, may help increase exercise tolerance, enabling patients to better engage in and benefit from cardiac rehabilitation programs.